FDA approves new orphan drug to treat a form of Gaucher disease
date:May 04, 2012
th evaluation period.


The most common side effects reported during clinical studies were infusion reactions and allergic reactions. Symptoms of infusion reactions include headache, chest pain or discomfort, weakness, fatigue, hives, skin redness, increased blood pressure, back pain, joint pain, and flushing. As with other intravenous protein products, anaphylaxis has been observed in some patients during Elelyso infusions.


Other commonly observed side effects observed in greater than 10 perc
6/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/01 12:09